ClinicalTrials.gg
CompletedNCT07945366Updated Nov 18, 2026

Artificial Intelligence-Based Eye Disease Diagnosis in Hospital Eye Clinics

An observational study in Eye Diseases, Glaucoma and Diabetic Retinopathy (DR), sponsored by Tsinghua University. Completed at 1 site in China. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Tsinghua University · Observational

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,196
Sex
All
01

Study summary

The goal of this observational study is to evaluate the diagnostic performance of an artificial intelligence (AI) program that analyzes color fundus photographs (CFP) taken during routine eye care in hospital clinics.

The main question it aims to answer is: What is the diagnostic performance of the AI program for eye diseases? Participants were patients attending the eye clinics of a hospital in Beijing, China, who had CFPs taken as part of their usual care. Participants did not have any extra tests or visits for research purposes. The AI program analyzed these photographs automatically, but its results were not shown to doctors or patients and did not change any part of their care. Researchers analyzed the AI results using records with names and other identifying information removed.

02

Conditions studied

  • Eye Diseases
  • Glaucoma
  • Diabetic Retinopathy (DR)
  • Age-Related Macular Degeneration (AMD)
  • Retinal Vein Occlusion (RVO)
  • Pathologic Myopia
  • Cataract
03

In context

Eye Diseases

389 studies on the registry are indexed under Eye Diseases; 62 are open to participants now.

This study's enrollment of 2,196 is above the median of 180 across 109 observational studies indexed under Eye Diseases.

Browse Eye Diseases studies →

Lead sponsor

Tsinghua University is the lead sponsor of 28 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Sampling method
Probability sample

Study population

Patients seen in the outpatient eye clinics of a tertiary hospital in Beijing, China. Participants were identified from routine clinical care; no one was recruited specifically for this study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Visited the clinic of a participating ophthalmologist during the study period
  • Underwent color fundus photography of at least one eye on the day of the visit, with AI output available

Exclusion criteria

Exclusion Criteria:

  • Subsequent visits by the same patient during the study period
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,196 participants (actual)
Patient registry
No

Interventions

  • Diagnostic testArtificial Intelligence

    An artificial intelligence program, integrated into the hospital information system, automatically analyzed each color fundus photograph taken during routine care.

06

What researchers measure

Primary outcomes

  1. Sensitivity of the Artificial Intelligence Model for Detecting Eye Diseases

    AI outputs were generated in real time from color fundus photographs obtained at the included clinic visit.

    Time frame: Day 1

  2. Specificity of the Artificial Intelligence Model for Detecting Eye Diseases

    AI outputs were generated in real time from color fundus photographs obtained at the included clinic visit.

    Time frame: Day 1

  3. Area Under the Receiver Operating Characteristic Curve (AUC) of the Artificial Intelligence Model for Detecting Eye Diseases

    AI outputs were generated in real time from color fundus photographs obtained at the included clinic visit.

    Time frame: Day 1

07

Study locations

1 site
  • Beijing Tsinghua Changgung Hospital
    Beijing, 100084, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2026 to primary completion in May 2026, 4 months.

Of 53 observational studies under Eye Diseases, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 86. This study's 4 months is below that.

Eye Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 11, 2026
First posted
Nov 18, 2026
StartActual
Jan 1, 2026
Primary completionActual
May 31, 2026
CompletionActual
May 31, 2026
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07945366
Lead sponsor
Tsinghua University
Responsible party
Tien Yin Wong (Professor, Tsinghua University) — Principal investigator
First posted
Nov 18, 2026
Start date
Jan 1, 2026
Primary completion
May 31, 2026
Completion
May 31, 2026
Last update
Nov 18, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion